pharmacokinetic (PK)
Showing 1 - 25 of >10,000
Epilepsy Trial in Wuhan (Lacosamide Tablets, Lacosamide extended release tablets)
Not yet recruiting
- Epilepsy
- Lacosamide Tablets
- Lacosamide extended release tablets
-
Wuhan, Hubei, ChinaUnion Hospital of Tongji Medical College of Huazhong University
Mar 15, 2023
Medical Device Derived Pharmacokinetic Parameters for Vancomycin
Not yet recruiting
- Infection, Bacterial
- +7 more
- Drug Infusion Pump Monitoring
-
London, United KingdomSt Georges University Hospitals NHS Foundation Trust
Jul 10, 2023
Squamous Cell Carcinoma of the Oral Cavity Trial in Milwaukee (Antitumor B)
Active, not recruiting
- Squamous Cell Carcinoma of the Oral Cavity
- Antitumor B
-
Milwaukee, WisconsinFroedtert Hospital and the Medical College of Wisconsin
Jan 18, 2023
Partial Seizure Trial in Tianjin (Brivaracetam tablets (50mg/ tablet, BRIVIACT®, UCB), Brivaracetam sustained-release tablets
Active, not recruiting
- Partial Seizure
- Brivaracetam tablets (50mg/ tablet, BRIVIACT®, UCB)
- +2 more
-
Tianjin, Tianjin, ChinaTianjin Municipal People's Hospital
Jan 31, 2023
Pain, Insomnia Trial in Guangzhou (Compound ibuprofen polyrelease tablets, reference 1 (R1): Ibuprofen Tablets (Motrin
Not yet recruiting
- Pain
- Insomnia
- Compound ibuprofen polyrelease tablets
- reference 1 (R1): Ibuprofen Tablets (Motrin IB®)reference 2 (R2): Diphenhydramine Hydrochloride Tablets (Benadryl®)
-
Guangzhou, Guangdong, ChinaZhujiang Hospital of Southern Medical University
Feb 6, 2023
Biological Markers, Diet, Healthy, Metabolomics Trial (Pharmacokinetic (PK)- Controlled Feeding Diet, Dose Response (DR)-
Recruiting
- Biological Markers
- +3 more
- Pharmacokinetic (PK)- Controlled Feeding Diet
- Dose Response (DR)- Controlled Feeding Diet
-
Boston, MassachusettsMass General Brigham Center for Clinical Investigation
Feb 1, 2023
Healthy Male Subjects Trial (AK104 (before the change), AK104 (after the change))
Not yet recruiting
- Healthy Male Subjects
- AK104 (before the change)
- AK104 (after the change)
- (no location specified)
Sep 26, 2022
Kidney Transplantation, Pancreas Transplantation, Diabetes Trial in Nantes (Tacrolimus and Tacrolimus Extended Release Oral
Recruiting
- Kidney Transplantation
- +2 more
- Tacrolimus and Tacrolimus Extended Release Oral Tablet [Envarsus]
-
Nantes, FranceNantes University Hospital
Aug 10, 2022
Heart Failure With Reduced Ejection Fraction Trial (AC01)
Not yet recruiting
- Heart Failure With Reduced Ejection Fraction
- (no location specified)
Jan 31, 2023
Pharmacokinetics, Absorption; Chemicals Trial in West Bend (Bemotrizinol (6%))
Active, not recruiting
- Pharmacokinetics
- Absorption; Chemicals
- Bemotrizinol (6%)
-
West Bend, WisconsinSpaulding Clinical Research LLC
Aug 25, 2022
Healthy Volunteer Trial in Anaheim, Miami, Springfield (Aducanumab)
Completed
- Healthy Volunteer
- Aducanumab
-
Anaheim, California
- +2 more
Aug 24, 2022
Cirrhosis, Liver Trial in Washington (Proglumide)
Completed
- Cirrhosis, Liver
-
Washington, District of ColumbiaGeorgetown University
Mar 14, 2022
HER2-positive Advanced Solid Tumor Trial in Zigong (ZV0203)
Enrolling by invitation
- HER2-positive Advanced Solid Tumor
-
Zigong, Shandong, ChinaPKUCare Luzhong Hospital
Jun 14, 2022
Hemophilia Trial in Bangkok (combination between moderate to vigorous-intensity physical activities and pharmacokinetic-guided
Completed
- Hemophilia
- combination between moderate to vigorous-intensity physical activities and pharmacokinetic-guided extended half-life FVIII concentrates prophylaxis
- pharmacokinetic-guided extended half-life FVIII concentrates prophylaxis alone
-
Bangkok, ThailandKing Chulalongkorn Memorial Hospital
Feb 5, 2023
MDS Trial in Hangzhou (IV Decitabine, Decitabine and cedazuridine, only Decitabine and cedazuridine)
Recruiting
- Myelodysplastic Syndromes
- IV Decitabine
- +2 more
-
Hangzhou, Zhejiang, ChinaThe First Affiliated Hospital,Zhejiang University School of Medi
Oct 23, 2023
Healthy Subjects Trial in Cheongju-si (DW6014)
Completed
- Healthy Subjects
-
Cheongju-si, Korea, Republic ofChungbuk National University Hospital
Apr 10, 2023
DW6014 Trial in Cheongju-si (DW6014)
Not yet recruiting
- DW6014
-
Cheongju-si, Korea, Republic ofChungbuk National University Hospital
Apr 10, 2023
Ménière's Disease Trial in Munich (Betahistine diHCl, Selegiline-HCl)
Completed
- Ménière's Disease
- Betahistine dihydrochloride
- Selegiline-hydrochloride
-
Munich, Bavaria, GermanyDepartment of Neurology, Ludwig Maximilian University
Jul 10, 2023
Normal Drug Tolerance Trial in Hartford (TP-434 (Eravacycline) reconstituted and administered via an IV infusion)
Completed
- Normal Drug Tolerance
- TP-434 (Eravacycline) reconstituted and administered via an IV infusion
-
Hartford, ConnecticutCenter for Anti-infective Research and Development; Hartford Hos
Dec 16, 2021
AUD Trial in Changsha (Naltrexone implant, Placebo)
Recruiting
- AUD
- Naltrexone implant
- Placebo
-
Changsha, 湖南省, ChinaHunan Second People's Hospital
Jun 23, 2023
Cystinosis Trial (Cysteamine Bitartrate, N-Acetylcysteine Amide)
Not yet recruiting
- Cystinosis
- Cysteamine Bitartrate
- N-Acetylcysteine Amide
- (no location specified)
Aug 15, 2023